Target intelligence / Profile preview

Ovum

Molecular classification
Other (gamete; not a receptor, enzyme, transporter, or typical molecular target)
01

Overview

The term "Ova fertilization in uterine environment" does not refer to a specific molecule or receptor but rather describes the process by which an ovum (egg cell) is fertilized by sperm within the female reproductive tract. In humans and most mammals, fertilization occurs in the fallopian tube—not directly within the uterus—where one sperm penetrates an ovum to form a zygote. The zygote then travels to the uterus for implantation and further development into an embryo and fetus[2][4][7]. The ovum itself is produced by the ovaries during each menstrual cycle and contains half of the genetic material required for human reproduction. It plays essential roles in reproduction by enabling gamete fusion with sperm, supporting early embryonic development through nutrient provision until implantation, and transmitting maternal genetic information to offspring. Disorders affecting ova can lead to infertility or developmental abnormalities. However, "ova" are not considered therapeutic targets like receptors or enzymes—they are cells involved in physiological processes rather than molecules that can be modulated pharmacologically[4][5]. Note on correctness: The entry "Ova fertilization in uterine environment" is incorrect as a molecular/receptor target because it refers broadly to a biological process rather than any single protein/gene/receptor/enzyme that could be targeted therapeutically. If you seek structured data on actual molecular targets involved in this process—such as zona pellucida glycoproteins or specific receptors mediating sperm–egg interaction—please specify those molecules individually for accurate mapping.

Other names
Egg cellOocyteFemale gamete
02

Biological functions

ReproductionGamete fusion (fertilization)Early embryonic developmentGenetic material transmissionCell division initiation
03

Disease associations

Infertility (due to ovulatory disorders or poor egg quality)[5]Chromosomal abnormalities in offspring[5]Ectopic pregnancy risk if fertilization/transport is impaired[2]
04

Safety considerations

Age-related decline in egg quality and quantity[5]Environmental toxins affecting ova health[5]Genetic conditions impacting oocyte function and embryo viability[5]
05

Biomarkers

Ovarian reserve markers for fertility assessment (e.g., Anti-Müllerian hormone)Follicle-stimulating hormone levels

Beyond the preview

Go deeper on Ovum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call